Clinical usefulness of gefitinib for non-small-cell lung cancer with a double epidermal growth factor receptor mutation

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 329-333

Science Publishers

Access to resources Recommend Favorite

Epidermal growth factor receptor gene mutation status and its association with clinical characteristics and tumor markers in nonsmallcell lung cancer patients in Northwest China

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 847-850

Science Publishers

Access to resources Recommend Favorite

Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer

By Chu Huili   Zhong Chen   Xue Guoliang   Liang Xiuju   Wang Jun   Liu Yingxin   Zhao Shiwei   Zhou Qian   Bi Jingwang  

Oncology Reports, Vol. 30, Iss. 5, 2013-11 ,pp. : 2311-2315

Spandidos Publications

Access to resources Recommend Favorite

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

By Tsuboi Masahiro   Chevalier Thierry  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 161-170

Humana Press, Inc

Access to resources Recommend Favorite

Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance

By              

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 393-398

Spandidos Publications

Access to resources Recommend Favorite